Legis Daily

To amend the Controlled Substances Act to strike the definition of "imminent danger to the public health or safety" that was added by Public Law 114-145 for purposes of suspending a registration.

USA115th CongressHR-4073| House 
| Updated: 11/1/2017
Gerald E. Connolly

Gerald E. Connolly

Democratic Representative

Virginia

Cosponsors (19)
Tim Ryan (Democratic)Richard M. Nolan (Democratic)Carol Shea-Porter (Democratic)Steve Cohen (Democratic)Adriano Espaillat (Democratic)Michelle Lujan Grisham (Democratic)Ro Khanna (Democratic)Elizabeth H. Esty (Democratic)Walter B. Jones (Republican)Mark DeSaulnier (Democratic)David E. Price (Democratic)Theodore E. Deutch (Democratic)Eleanor Holmes Norton (Democratic)Lois Frankel (Democratic)Rick Larsen (Democratic)Suzanne Bonamici (Democratic)Ed Perlmutter (Democratic)John K. Delaney (Democratic)Grace Meng (Democratic)

Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Opioid Immediate Suspension Order Act of 2017 This bill amends the Controlled Substances Act to eliminate the provision that defines the phrase "imminent danger to the public health and safety." Under current law, the Drug Enforcement Administration may immediately suspend the registration of a controlled substances manufacturer, distributor, or dispenser to prevent imminent danger to the public health and safety.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 16, 2017
Introduced in House
Oct 16, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 20, 2017
Referred to the Subcommittee on Health.
Nov 1, 2017
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
  • October 16, 2017
    Introduced in House


  • October 16, 2017
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • October 20, 2017
    Referred to the Subcommittee on Health.


  • November 1, 2017
    Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Crime and Law Enforcement

Drug trafficking and controlled substancesLicensing and registrationsPrescription drugsRetail and wholesale trades

To amend the Controlled Substances Act to strike the definition of "imminent danger to the public health or safety" that was added by Public Law 114-145 for purposes of suspending a registration.

USA115th CongressHR-4073| House 
| Updated: 11/1/2017
Opioid Immediate Suspension Order Act of 2017 This bill amends the Controlled Substances Act to eliminate the provision that defines the phrase "imminent danger to the public health and safety." Under current law, the Drug Enforcement Administration may immediately suspend the registration of a controlled substances manufacturer, distributor, or dispenser to prevent imminent danger to the public health and safety.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 16, 2017
Introduced in House
Oct 16, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 20, 2017
Referred to the Subcommittee on Health.
Nov 1, 2017
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
  • October 16, 2017
    Introduced in House


  • October 16, 2017
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • October 20, 2017
    Referred to the Subcommittee on Health.


  • November 1, 2017
    Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Gerald E. Connolly

Gerald E. Connolly

Democratic Representative

Virginia

Cosponsors (19)
Tim Ryan (Democratic)Richard M. Nolan (Democratic)Carol Shea-Porter (Democratic)Steve Cohen (Democratic)Adriano Espaillat (Democratic)Michelle Lujan Grisham (Democratic)Ro Khanna (Democratic)Elizabeth H. Esty (Democratic)Walter B. Jones (Republican)Mark DeSaulnier (Democratic)David E. Price (Democratic)Theodore E. Deutch (Democratic)Eleanor Holmes Norton (Democratic)Lois Frankel (Democratic)Rick Larsen (Democratic)Suzanne Bonamici (Democratic)Ed Perlmutter (Democratic)John K. Delaney (Democratic)Grace Meng (Democratic)

Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

Crime and Law Enforcement

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Drug trafficking and controlled substancesLicensing and registrationsPrescription drugsRetail and wholesale trades